MedTrace Logo

Droxidopa in Treating Patients With Neurogenic Hypotension

NCT00004478 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2008-09-18

No results posted yet for this study

Summary

Please note that the continuation study can be found at http://clinicaltrials.gov/show/NCT00633880.

RATIONALE: Neurogenic hypotension is a fall in blood pressure that occurs when one moves from a lying down to a standing position or after eating a meal. It causes one to feel dizzy, light headed, and weak. Neurogenic hypotension is caused by a problem in the part of the nervous system that controls such functions as heart rate and blood pressure. Droxidopa, a drug that may increase blood pressure, may be an effective treatment for neurogenic hypotension.

PURPOSE: Clinical trial to study the effectiveness of droxidopa in treating patients who have neurogenic hypotension.

Conditions

  • Shy-Drager Syndrome
  • Orthostatic Hypotension

Interventions

DRUG

droxidopa

Sponsors & Collaborators

Principal Investigators

  • Horacio Kaufmann, MD · NYU Langone Health

Study Design

Purpose
TREATMENT

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-03-31
Primary Completion
2006-03-31
Completion
2006-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004478 on ClinicalTrials.gov